New Life Scientific, Inc (OTC BB: NWLS) today announced that it has entered into a strategic alliance with Biorigen Srl, (Genoa, Italy), a Biotech Company with certain intellectual properties and Centro Biotecnologie Avanzate (Genoa, Italy) to pursue development of a series of research projects, the first one being the project of "Bone Repair by Tissue Engineering" that is using novel biotechnology. Under the agreement, NWLS and Biorigen are to establish a joint venture, which obtains global rights with Biorigen Srl retaining rights for the European Union and countries of the Mediterranean Basin and Middle East.
